Colostrinin is a proline-rich polypeptide complex produced from colostrum and is under development as a neutraceutical treatment for 'the prevention of cognitive decline' in both humans and animals. More
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
AT9283 is a potent aurora (A and B) kinase inhibitor for the treatment of multiple solid tumour and haematological malignancies IND approved: April 2006 More
Displaying 1..10 of 47 -
per page
Next page
Order by